Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7UZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,046
Award facts
- Contract value 100% obligated
- $39,046.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $39,046.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on January 8, 2026, with a completion date of January 9, 2026. The contract is not set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at up to $999,999,999.00 and extending through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider. The company competes on a full and open basis for federal contracts and has demonstrated significant capability in fulfilling government medical supply needs across multiple therapeutic domains, including neurological treatments such as Vraylar. The DLA Troop Support Medical IDC encompasses an extensive variety of medical commodities—including specialty medications, brand-name and generic drugs, vaccines, syringes, and test kits—enabling efficient procurement to support military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F7UZ5?
SPE2DR26F7UZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F7UZ5 worth?
The government has obligated $39,046 on SPE2DR26F7UZ5.
Is contract SPE2DR26F7UZ5 an order under another contract?
Yes. SPE2DR26F7UZ5 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UZ5 competed?
The extent of competition for SPE2DR26F7UZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award